Search

everythinglearnresearchcommunity

for

Search:↓

Inclusive and affirming healthcare is essential for improving transgender individuals' quality of life and health.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Transgender and gender diverse youth often have skin issues like acne and scarring, but few get referred to dermatologists.

Facial hair is crucial for transgender men's gender identity and transition.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.

Gender-affirming hormone therapy may increase heart disease risk in transgender individuals.

Denying transgender minors gender-affirming care, while allowing it for cisgender minors, is sex discrimination.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Social rejection can harm long-term mental health in transgender individuals.

Dermatologists should guide transgender patients on effective hair growth and loss treatments during hormone therapy.

Non-surgical treatments can significantly reduce keloids in children, with combination therapies being safer and more effective.

Bicalutamide may help treat female pattern hair loss.

A transman experienced lasting virilization symptoms after stopping testosterone, which were resolved with estradiol treatment.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.

Creating evidence-based guidelines for gender incongruence is difficult due to the personalized nature of transgender medicine.

Gender affects hair and scalp characteristics, with differences in hormone responses, graying patterns, and trace metals.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Testosterone treatment effectively causes male physical development in transgender male adolescents but may lead to side effects like acne, higher BMI and blood pressure, lower good cholesterol, and decreased bone density.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Facial feminization surgery helps make facial features more feminine, improving patient satisfaction and safety.

Testosterone pellets might work for transgender men's hormone therapy, but more research is needed.

Proper planning and technique in upper-face feminization surgery are crucial to avoid complications and revisions.

Facial contouring is crucial for the satisfaction and well-being of Chinese transgender females.

Alopecia in transgender individuals on hormone therapy can worsen emotional distress and affect self-esteem.

The document concludes that careful planning and execution of facial gender affirmation surgery after at least 12 months of hormonal therapy can improve the quality of life for transgender individuals.

More research is needed to improve lower body gender affirmation techniques.

Hormonal therapy for transgender individuals carries health risks but is a personal choice.